Report Detail

Pharma & Healthcare Global Eye Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4586320
  • |
  • 09 April, 2024
  • |
  • Global
  • |
  • 109 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Eye Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Eye Injection industry chain, the market status of Age-related Macular Degeneration (AMD) (Ranibizumab, Bevacizumab), Diabetic Retinopathy (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Eye Injection.
Regionally, the report analyzes the Eye Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Eye Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Eye Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Eye Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Eye Injection market.
Regional Analysis: The report involves examining the Eye Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Eye Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Eye Injection:
Company Analysis: Report covers individual Eye Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Eye Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration (AMD), Diabetic Retinopathy).
Technology Analysis: Report covers specific technologies relevant to Eye Injection. It assesses the current state, advancements, and potential future developments in Eye Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Eye Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Eye Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Market segment by Application
Age-related Macular Degeneration (AMD)
Diabetic Retinopathy
Retinal Vein Occlusion (RVO)
Retinopathy of Prematurity (ROP)
Uveitis
Neovascular Glaucoma
Others
Major players covered
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Roche
Fagron
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eye Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Eye Injection, with price, sales, revenue and global market share of Eye Injection from 2019 to 2024.
Chapter 3, the Eye Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eye Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Eye Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Eye Injection.
Chapter 14 and 15, to describe Eye Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Eye Injection
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Eye Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Ranibizumab
    • 1.3.3 Bevacizumab
    • 1.3.4 Aflibercept
    • 1.3.5 Brolucizumab
    • 1.3.6 Faricimab
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Eye Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Age-related Macular Degeneration (AMD)
    • 1.4.3 Diabetic Retinopathy
    • 1.4.4 Retinal Vein Occlusion (RVO)
    • 1.4.5 Retinopathy of Prematurity (ROP)
    • 1.4.6 Uveitis
    • 1.4.7 Neovascular Glaucoma
    • 1.4.8 Others
  • 1.5 Global Eye Injection Market Size & Forecast
    • 1.5.1 Global Eye Injection Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Eye Injection Sales Quantity (2019-2030)
    • 1.5.3 Global Eye Injection Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Eye Injection Product and Services
    • 2.1.4 Sanofi Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Eye Injection Product and Services
    • 2.2.4 Novartis Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments/Updates
  • 2.3 Bayer
    • 2.3.1 Bayer Details
    • 2.3.2 Bayer Major Business
    • 2.3.3 Bayer Eye Injection Product and Services
    • 2.3.4 Bayer Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bayer Recent Developments/Updates
  • 2.4 Genentech
    • 2.4.1 Genentech Details
    • 2.4.2 Genentech Major Business
    • 2.4.3 Genentech Eye Injection Product and Services
    • 2.4.4 Genentech Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Genentech Recent Developments/Updates
  • 2.5 Apellis Pharmaceuticals, Inc.
    • 2.5.1 Apellis Pharmaceuticals, Inc. Details
    • 2.5.2 Apellis Pharmaceuticals, Inc. Major Business
    • 2.5.3 Apellis Pharmaceuticals, Inc. Eye Injection Product and Services
    • 2.5.4 Apellis Pharmaceuticals, Inc. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
  • 2.6 Coherus BioSciences Inc.
    • 2.6.1 Coherus BioSciences Inc. Details
    • 2.6.2 Coherus BioSciences Inc. Major Business
    • 2.6.3 Coherus BioSciences Inc. Eye Injection Product and Services
    • 2.6.4 Coherus BioSciences Inc. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
  • 2.7 Iveric Bio
    • 2.7.1 Iveric Bio Details
    • 2.7.2 Iveric Bio Major Business
    • 2.7.3 Iveric Bio Eye Injection Product and Services
    • 2.7.4 Iveric Bio Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Iveric Bio Recent Developments/Updates
  • 2.8 Regeneron
    • 2.8.1 Regeneron Details
    • 2.8.2 Regeneron Major Business
    • 2.8.3 Regeneron Eye Injection Product and Services
    • 2.8.4 Regeneron Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Regeneron Recent Developments/Updates
  • 2.9 Roche
    • 2.9.1 Roche Details
    • 2.9.2 Roche Major Business
    • 2.9.3 Roche Eye Injection Product and Services
    • 2.9.4 Roche Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Roche Recent Developments/Updates
  • 2.10 Fagron
    • 2.10.1 Fagron Details
    • 2.10.2 Fagron Major Business
    • 2.10.3 Fagron Eye Injection Product and Services
    • 2.10.4 Fagron Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Fagron Recent Developments/Updates
  • 2.11 Qilu Pharmaceutical Co.,Ltd.
    • 2.11.1 Qilu Pharmaceutical Co.,Ltd. Details
    • 2.11.2 Qilu Pharmaceutical Co.,Ltd. Major Business
    • 2.11.3 Qilu Pharmaceutical Co.,Ltd. Eye Injection Product and Services
    • 2.11.4 Qilu Pharmaceutical Co.,Ltd. Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.12 Chengdu Kanghong Pharmaceutical Group
    • 2.12.1 Chengdu Kanghong Pharmaceutical Group Details
    • 2.12.2 Chengdu Kanghong Pharmaceutical Group Major Business
    • 2.12.3 Chengdu Kanghong Pharmaceutical Group Eye Injection Product and Services
    • 2.12.4 Chengdu Kanghong Pharmaceutical Group Eye Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Eye Injection by Manufacturer

  • 3.1 Global Eye Injection Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Eye Injection Revenue by Manufacturer (2019-2024)
  • 3.3 Global Eye Injection Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Eye Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Eye Injection Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Eye Injection Manufacturer Market Share in 2023
  • 3.5 Eye Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Eye Injection Market: Region Footprint
    • 3.5.2 Eye Injection Market: Company Product Type Footprint
    • 3.5.3 Eye Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Eye Injection Market Size by Region
    • 4.1.1 Global Eye Injection Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Eye Injection Consumption Value by Region (2019-2030)
    • 4.1.3 Global Eye Injection Average Price by Region (2019-2030)
  • 4.2 North America Eye Injection Consumption Value (2019-2030)
  • 4.3 Europe Eye Injection Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Eye Injection Consumption Value (2019-2030)
  • 4.5 South America Eye Injection Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Eye Injection Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Eye Injection Sales Quantity by Type (2019-2030)
  • 5.2 Global Eye Injection Consumption Value by Type (2019-2030)
  • 5.3 Global Eye Injection Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Eye Injection Sales Quantity by Application (2019-2030)
  • 6.2 Global Eye Injection Consumption Value by Application (2019-2030)
  • 6.3 Global Eye Injection Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Eye Injection Sales Quantity by Type (2019-2030)
  • 7.2 North America Eye Injection Sales Quantity by Application (2019-2030)
  • 7.3 North America Eye Injection Market Size by Country
    • 7.3.1 North America Eye Injection Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Eye Injection Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Eye Injection Sales Quantity by Type (2019-2030)
  • 8.2 Europe Eye Injection Sales Quantity by Application (2019-2030)
  • 8.3 Europe Eye Injection Market Size by Country
    • 8.3.1 Europe Eye Injection Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Eye Injection Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Eye Injection Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Eye Injection Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Eye Injection Market Size by Region
    • 9.3.1 Asia-Pacific Eye Injection Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Eye Injection Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Eye Injection Sales Quantity by Type (2019-2030)
  • 10.2 South America Eye Injection Sales Quantity by Application (2019-2030)
  • 10.3 South America Eye Injection Market Size by Country
    • 10.3.1 South America Eye Injection Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Eye Injection Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Eye Injection Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Eye Injection Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Eye Injection Market Size by Country
    • 11.3.1 Middle East & Africa Eye Injection Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Eye Injection Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Eye Injection Market Drivers
  • 12.2 Eye Injection Market Restraints
  • 12.3 Eye Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Eye Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Eye Injection
  • 13.3 Eye Injection Production Process
  • 13.4 Eye Injection Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Eye Injection Typical Distributors
  • 14.3 Eye Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Eye Injection. Industry analysis & Market Report on Eye Injection is a syndicated market report, published as Global Eye Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Eye Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,735.28
    4,102.92
    5,470.56
    3,212.04
    4,818.06
    6,424.08
    546,394.80
    819,592.20
    1,092,789.60
    289,222.80
    433,834.20
    578,445.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report